Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.17
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
15.22
0.33%
After-hours: Aug 15, 2025, 06:46 PM EDT
Immunovant Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Cash & Equivalents | 598.91M | 713.97M | 374.69M | 472.94M | 560M | 635.37M | 690.94M | 269.93M | 329.96M | 376.53M | 432.61M | 405.77M | 427.2M | 493.82M | 527M | 558.95M | 379M | 400.15M | 421.97M | 444.37M | 280.28M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 8.94M | 7.62M | 7.62M | 7.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 1.94M | 2.51M | 2.22M | 1.88M | 2.42M | 5.5M | 1.03M | 1.42M | 823K | 885K | 704K | 3.78M | 13.18M | 12.86M | n/a | n/a | n/a | 1.14M | 481K | 40K | 24K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a |
Other Current Assets | 50.91M | 51.18M | 35.63M | 32.55M | 26.63M | 24.9M | 18.81M | 19.83M | 19.23M | n/a | 21.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 651.76M | 767.66M | 412.54M | 507.37M | 589.05M | 665.77M | 710.78M | 291.18M | 350.01M | 404.33M | 454.42M | 426.09M | 456.3M | 512.93M | 540.48M | 563.79M | 384.83M | 409.01M | 429.43M | 450.27M | 286.12M |
Property-Plant & Equipment | 737K | 942K | 774K | 716K | 631K | 595K | 670K | 893K | 1.21M | 1.5M | 1.82M | 2.06M | 2.35M | 2.63M | 2.7M | 2.94M | 3.2M | 3.48M | 3.6M | 3.63M | 4.17M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 9.68M | 8.56M | 8.39M | 8.34M | 631K | 942K | 670K | 893K | 1.21M | 1.5M | 1.82M | 2.06M | 2.35M | 2.63M | 2.7M | 2.94M | 3.2M | 3.48M | 3.6M | 3.63M | 4.17M |
Total Assets | 661.44M | 776.22M | 420.93M | 515.71M | 589.68M | 666.71M | 711.45M | 292.07M | 351.22M | 405.84M | 456.24M | 428.15M | 458.66M | 515.56M | 543.18M | 566.73M | 388.03M | 412.49M | 433.03M | 453.89M | 290.29M |
Account Payables | 7.84M | 17.66M | 19.82M | 20.73M | 11.04M | 7.16M | 3.91M | 7.51M | 26.46M | 1.35M | 14M | 7.46M | 1.07M | 18.63M | 3.83M | 4.24M | 3.11M | 2.43M | 2.1M | 5.79M | 8.01M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 98K | 23K | 47K | 69K | 138K | 306K | 614K | 919K | n/a | 1.21M | 1.19M | 1.17M | n/a | 1.08M | 1.08M | 1.08M | 1.18M | 1.1M | n/a | 1.1M |
Other Current Liabilities | 39.08M | 15.52M | 48.45M | 45.83M | 30.44M | 26.42M | 20.11M | 26.67M | 20.61M | 350K | 19.5M | 18.35M | 15.8M | 171K | 27.86M | 20.18M | 13.89M | 10.84M | 10.09M | 4.58M | 8.42M |
Total Current Liabilities | 52.9M | 68.78M | 68.31M | 66.65M | 45.02M | 48.61M | 32.1M | 40.26M | 51.36M | 43.3M | 41.26M | 31.78M | 21.24M | 44.52M | 36.35M | 28.38M | 20.52M | 18.77M | 16.48M | 12.81M | 19.54M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | -347K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 1.1M | n/a | n/a | n/a | 347K | n/a | n/a | n/a | 47K | 306K | 614K | 919K | 1.22M | 1.68M | 1.95M | 1.97M | 2.24M | 2.39M | 2.68M | 2.97M |
Total Liabilities | 52.9M | 68.78M | 68.31M | 66.65M | 45.02M | 48.95M | 32.1M | 40.26M | 51.36M | 43.34M | 41.56M | 32.4M | 22.16M | 45.74M | 38.03M | 30.34M | 22.5M | 21.01M | 18.88M | 15.49M | 22.52M |
Total Debt | n/a | 98K | 23K | 47K | 69K | 138K | 306K | 614K | 919K | 1.22M | 1.51M | 1.8M | 2.08M | 2.36M | 2.76M | 3.03M | 3.06M | 3.42M | 3.5M | 3.78M | 4.07M |
Common Stock | 16K | 16K | 14K | 14K | 14K | 14K | 14K | 13K | 13K | 13K | 13K | 12K | 12K | 12K | 12K | 12K | 10K | 10K | 10K | 10K | 8K |
Retained Earnings | -1.36B | -1.24B | -1.13B | -1.02B | -912.83M | -825.68M | -750.36M | -698.95M | -640.28M | -566.35M | -506.92M | -443.69M | -395.76M | -355.39M | -308.22M | -266.83M | -229.13M | -198.66M | -170.5M | -138.72M | -117.93M |
Comprehensive Income | 1.74M | 1.46M | 2.48M | 1.91M | 1.82M | 1.91M | -600K | 513K | 582K | 852K | 1.38M | -1.24M | -263K | 404K | 419K | 442K | 273K | -298K | 467K | -222K | 10K |
Shareholders Equity | 608.54M | 707.45M | 352.62M | 449.05M | 544.66M | 617.76M | 679.34M | 251.81M | 299.87M | 362.49M | 414.68M | 395.75M | 436.49M | 469.82M | 505.15M | 536.4M | 365.53M | 391.48M | 414.15M | 438.41M | 267.77M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |